Fusaroli, Michele http://orcid.org/0000-0002-0254-2212
Isgrò, Valentina
Cutroneo, Paola Maria http://orcid.org/0000-0002-6937-4495
Ferrajolo, Carmen http://orcid.org/0000-0002-6228-6548
Cirillo, Valentina
Del Bufalo, Francesca http://orcid.org/0000-0001-9643-3465
Raschi, Emanuel http://orcid.org/0000-0003-0487-7996
Poluzzi, Elisabetta http://orcid.org/0000-0002-7209-0426
Trifirò, Gianluca http://orcid.org/0000-0003-1147-7296
Funding for this research was provided by:
Alma Mater Studiorum - Università di Bologna
Article History
Accepted: 29 May 2022
First Online: 12 July 2022
Declarations
:
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
: MF, VI, PC, CF, FD, VC, and EP declare that they have no conflicts of interest. ER reports a personal fee for consultancy from Novartis, outside the submitted work. GT has served on advisory boards, seminars, masters, and projects funded by several pharmaceutical companies (Eli Lilly, Amgen, Sanofi, SOBI, Gilead, PTC Therapeutics, ABBvie, Verpora, Daiichi Sankyo), outside the submitted work.
: Anonymized data were collected from a publicly available database and do not require ethics committee approval.
: Not applicable.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available in the US FAERS repository.
: The R script developed for the analyses is available from the corresponding author upon reasonable request.
: MF, VI, PC, CF, ER, FD, VC, ER, EP, and GT conceived and executed the research project. MF designed and executed the statistical analysis. MF, VI, PC, CF, ER, EP, and GT reviewed and critiqued the statistical analysis. All the authors contributed to the interpretation of data. Regarding article preparation, the writing of the first draft was executed by MF and VI, and all the authors contributed to the review and critique. All the authors approved the final version.